跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 104,195 条关于
“fibrosing interstitial lung diseases”
全部
104,195
临床试验
88,018
药物
1,481
机构
374
资讯
14,322
去年
EMA Recommends Ofev for Progressive Fibrosing ILDs in Children and Adolescents
去年
EMA Grants Positive Opinion for Orphan Drug Designation to Nuformix's NXP002 for Idiopathic Pulmonary Fibrosis
2年前
Boehringer Ingelheim Seeks Approval for Nerandomilast After Positive Phase III IPF Trial
去年
EMA's CHMP Recommends Multiple New Medicines and расширения Indications in November and December 2024 Meetings
9个月前
PureTech's Deupirfenidone Receives FDA Backing for Phase 3 Trial in Idiopathic Pulmonary Fibrosis
去年
PureTech Health Launches Celea Therapeutics to Advance Phase 3-Ready IPF Treatment
去年
PureTech's Deupirfenidone Shows Unprecedented Efficacy in IPF Treatment, Phase 2b Results to be Presented at ATS Conference
2个月前
Celea Therapeutics Secures $180 Million to Launch First Head-to-Head Phase 3 Trial of Deupirfenidone in IPF
去年
Boehringer Ingelheim Secures UPC Court Victory Protecting Nintedanib Patent Against Generic Competition
去年
Boehringer Ingelheim Prepares for Multiple New Product Launches in 2025 Following Strong R&D Investment
第 1 页，共 1433 页
上一页
下一页
